R oundabout 4 (Robo4) is a transmembrane receptor that belongs to the Robo family of neural cell adhesion molecules. Robo4 has been shown to play a role in endothelial cell (EC) migration, proliferation, angiogenesis, and stabilization of the vasculature. [1] [2] [3] [4] [5] Robo4 is expressed specifically in ECs 6,7 in the developing embryo, 1 placenta, 6 normal adult tissues, 1,8 and tumors. 6,8 Recently, shear stress was reported to suppress Robo4 gene expression. 9
transcription factors, such as SP1, ETS family proteins, nuclear factor-κB, and GATA proteins. 12 Although some transcription factors are enriched in ECs (eg, Vezf1 [vascular endothelial zinc finger], HoxA9 [homeobox], GATA2, and KLF2 [Krüppel-like factor]), none has been shown to be restricted to the endothelium.
Collectively, these findings argue against the existence of an endothelial-specific master regulator that mediates differentiation and expression of multiple differentiation markers, as MyoD (myogenic differentiation) does in skeletal myocytes. 13 One possibility is that EC-specific gene expression is mediated by the cooperative activity of multiple noncell-type-specific transcription factors. Alternatively, unique post-translational modifications or alternative spliced transcripts may play a role. Finally, there is increasing evidence that epigenetic mechanisms contribute to cell-type-specific expression of genes in the endothelium. 14, 15 Epigenetic control of gene transcription involves DNA methylation, histone modification, and chromatin remodeling. DNA methylation refers to the addition of a methyl group to the 5′-position of cytosine to create 5-methyl-cytosine. DNA methylation at cytosine residues occurs almost exclusively in the context of the CpG sequence in the vertebrate genome. DNA methylation is a repressive mark that is associated with transcriptional silencing. 16 It has been implicated in many cellular processes, including X chromosome inactivation, genomic imprinting, embryonic development, lineage specification, and cancer pathogenesis. 15 Two general mechanisms have been proposed for CpG methylation-mediated gene suppression. First, DNA methylation may inhibit the binding of transcription factors to CpG dinucleotide-containing cis-regulatory elements. Second, DNA methylation results in the recruitment of methyl CpG-binding proteins. These proteins recruit large chromatinmodifying complexes and promote chromatin condensation that represses transcription by reducing DNA accessibility.
In this study, we hypothesized that EC-specific Robo4 gene expression is regulated by epigenetic mechanisms. We compared the DNA methylation pattern of the Robo4 promoter between EC and non-EC cell types and found that the proximal promoter region is methylated only in non-ECs. This celltype-specific methylation inhibited the binding of SP1 to the −42 SP1 site and suppressed Robo4 gene expression. Finally, using transgenic mice and an ES cell differentiation system, we demonstrated that the 0.3-kb proximal promoter, including 11 CpG sites, contained the information for EC-specific gene expression and that the EC-specific methylation pattern of the promoter is determined during cell differentiation. Collectively, these data support a novel model of EC-specific gene expression that involves DNA methylation-mediated inhibition of SP1 activity in non-ECs.
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Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results
Methylation Pattern of the Robo4 Promoter in ECs and Non-ECs
The upstream promoter (−3000 to +1) of the human Robo4 gene contains a total of 37 CpG sites and no typical CpG islands ( Figure 
Effects of DNA Methylation on Robo4 Gene Expression in ECs and Non-ECs
We next asked whether cell-type-specific methylation of the Robo4 promoter contributes to EC-specific expression of Robo4. To investigate the effects of promoter methylation on Robo4 gene expression, ECs (HCAEC) and non-ECs (HCASmC, normal human dermal fibroblasts, and HEK293) were treated with the DNA methyltransferase inhibitor 5-aza-2′deoxycytidine, and expression levels of the Robo4 mRNA were measured by real-time reverse transcription polymerase chain reaction. Treatment with 5-aza-2′-deoxycytidine did not affect Robo4 mRNA expression in HCAEC but significantly increased mRNA levels in HCASmC, normal human dermal fibroblasts, and HEK293 cells (by 4-fold, 7-fold, and 30-fold, respectively; Figure 2A ). These results suggest that DNA methylation of the Robo4 promoter serves to silence expression in non-ECs.
To determine the effect of CpG methylation on promoter activity, we performed transient transfection assays using Robo4 promoter-luciferase plasmids in which the proximal promoter (CpG sites from −826 to −43) was either unmethylated or methylated in vitro using Sss1 methylase ( Figure 2B ). As shown in Figure 2B , methylation of the proximal promoter resulted in a significant reduction of Robo4 promoter activity in HCAEC. Thus, DNA methylation of the proximal promoter suppresses Robo4 gene expression.
Effect of DNA Methylation on GABP and SP1 Binding to the Robo4 Promoter
One mechanism underlying the silencing effect of DNA methylation on gene expression is direct inhibition of transcription factor binding. We have previously shown that GABP and SP1 bind to an ETS site at −119 and SP1 sites at −42 and −153. All 3 DNA elements are flanked by CpG sites ( Figure 3A ). In addition, the −42 SP1 site has a CpG dinucleotide internal to the consensus motif. To investigate whether DNA methylation affects the binding of GABP and SP1 to their cis-elements, elecrophoretic mobility shift assay was performed using oligonucleotide probes in which these CpG sites were methylated or unmethylated ( Figure 3A) . Methylation of the −153 SP1 probe did not affect SP1 binding to the −153 SP1 site ( Figure 3B , left). Furthermore, in competition assays, cold unmethylated and methylated probes were effective in inhibiting binding of SP1 to the wild-type (WT) probe ( Figure 3B , right). Similarly, methylation of the −119 ETS probe had no effect on GABP binding ( Figure 3C ). In contrast, methylation of the −42 SP1 probe significantly inhibited SP1 binding, as evidenced by a loss of binding to the radiolabeled methylated probe ( Figure 3D , left) and lack of competition of SP1 binding to a WT unmethylated probe ( Figure 3D , right). These results suggest that DNA methylation suppresses Robo4 gene expression in non-ECs by inhibiting SP1 binding to the −42 SP1 site.
Chromatin Condensation of the Robo4 Promoter in ECs and Non-ECs
A second mechanism underlying the silencing effect of DNA methylation on gene expression is indirect inhibition of transcription factor binding through chromatin condensation. To investigate whether chromatin condensation plays a role in inhibiting Robo4 gene expression in non-ECs, we performed DNase hypersensitivity assays using micrococcal nuclease digestion of genomic DNA from HCAEC, HCASmC, and HEK293 cells (Figure 4 ). The chromatin was highly condensed around −2.5 kb in both ECs and non-ECs, which correlates with dense methylation in this region (Figure 1 ). In the proximal promoter region, chromatin condensation was low in ECs. Surprisingly, a similar pattern was observed in HCASmC. In contrast, chromatin condensation was higher in HEK293 cells. These data argue against a consistent role for chromatin condensation in silencing Robo4 gene expression in non-ECs.
EC-Specific Gene Expression of a 0.3-kb Proximal Promoter Fragment of Robo4 In Vivo
Our data suggest that the immediate 0.3-kb upstream promoter of Robo4 constitutes a differentially methylated region in ECs and non-ECs. To determine whether this region, which contains 11 CpG sites, is sufficient for mediating cell-type specificity in vivo, we generated transgenic mice carrying the 0.3-kb Robo4 promoter coupled to the LacZ gene (DEL [deletant]; Figure 5A ) and compared LacZ expression with mice carrying the 3-kb full-length promoter (WT; Figure 5A ). X-gal staining of wholemount organs showed that LacZ expression in the brain, lung, heart, and diaphragm was significantly lower in DEL mice compared with WT mice ( Figure 5B ). X-Gal staining of tissue sections showed a similar reduction in LacZ expression in the microvasculature of all 4 organs, whereas LacZ expression was still observed in ECs of larger blood vessels in the brain, lung, and diaphragm ( Figure 5C ). These data indicate that the 0.3-kb proximal promoter is sufficient for mediating EC-specific gene expression in vivo, although its promoter activity is weaker than that of the full-length promoter.
Differentiation Stage-Specific Methylation of the Robo4 Promoter During Differentiation of Hprt-Targeted ES Cells
To investigate the methylation pattern of the Robo4 promoter during cell differentiation, Hprt-targeted ES cells carrying 3-kb In undifferentiated ES cells, a high degree of methylation was observed throughout the promoter. DNA methylation progressively decreased during cell differentiation. Importantly, the 11 CpG sites in the proximal promoter were completely unmethylated in the Flk-1 + and CD31 + cells ( Figure 6 ; Figure IV in the online-only Data Supplement). These findings suggest that the EC-specific methylation pattern of the Robo4 promoter is determined by demethylation during cell differentiation.
To investigate the mechanism involved in demethylation of the proximal promoter during cell differentiation from ES cells into Flk-1 + cells, we analyzed whether GABP and SP1 binding to the promoter contributes to demethylation. Two ES cell lines containing the 3-kb Robo4 promoter with mutations either at the −119 ETS site or at the 2 SP1 sites (−153 and −142 SP1 sites) were differentiated, and methylation patterns of the proximal promoter in Flk-1 + cells were analyzed. In both mutant promoters, the proximal region showed a normal hypomethylated pattern similar to that of the WT promoter ( Figure 6B and 6C) . These results indicate that binding of GABP and SP1 to the proximal promoter is not essential for promoter demethylation.
Robo4 Expression and DNA Methylation in ECs Exposed to Shear Stress
Our data raise the interesting question of whether DNA methylation plays a physiological role in mediating temporal changes in Robo4 expression in ECs. A previous study by Bicknell et al showed that laminar shear stress suppresses Robo4 gene expression. 9 We asked whether suppression was regulated through the methylation of the proximal promoter. Human umbilical vein ECs were grown under static conditions or exposed to laminar shear stress (20 dyn/cm 2 ) for 24 hours and harvested for RNA and genomic DNA. In real-time reverse transcription polymerase chain reaction assays, laminar flow resulted in a significant reduction of Robo4 and an induction of KLF2 mRNA levels ( Figure VA in the online-only Data Supplement). However, shear stress did not induce proximal promoter methylation in ECs ( Figure VB in the onlineonly Data Supplement). These findings suggest that DNA methylation is not involved in mediating shear stressdependent repression of Robo4.
Discussion
Robo4 is selectively expressed in ECs. Thus, an understanding of its transcriptional control may provide insights into mechanisms of EC-specific gene expression. We have previously shown that GABP and SP1 positively regulate Robo4 promoter activity. However, these transcription factors are also expressed in other cell types. Thus, other mechanisms must be involved in mediating cell-type-specific expression of Robo4. Recent studies from the Marsden laboratory have demonstrated an important role for DNA methylation in mediating EC-specific expression of several genes, including those encoding endothelial nitric oxide synthase, vascular endothelial cadherin, CD31, von Willebrand factor, and intercellular adhesion molecule-2. 14, 17 The results of the present study support a similar role for DNA methylation in governing celltype-specific expression of Robo4.
The methylation pattern of the 5′-flanking region of Robo4 differed between ECs and non-ECs. This effect was most pronounced in the immediate 0.3-kb proximal promoter, in which all 11 CpG sites were heavily methylated in non-ECs but completely unmethylated in ECs. Studies in which the Robo4 promoter was either methylated or demethylated demonstrated a functional role for DNA methylation in repressing Robo4 expression in non-ECs. In Hprt-targeted mice, the 0.3-kb proximal promoter (containing the 11 CpG sites) region retained information for EC-specific gene expression. Taken together, these findings strongly suggest that differential DNA methylation in ECs and non-ECs contributes to cell-type-specific expression of Robo4. Two general mechanisms have been proposed for CpG methylation-mediated gene suppression. First, methylated CpG sites with or without methyl CpG-binding proteins prevent the binding of transcription factors, such as AP (activating protein)-2, HIF (hypoxia inducible factor)-1, and c-Myc (v-myc myelocytomatosis viral oncogene homolog), to their binding motifs in the promoters. [18] [19] [20] Second, methyl CpG-binding proteins recruit large chromatin-modifying complexes that reduce DNA accessibility by changing chromatin structure.
We first investigated whether DNA methylation interferes with binding of transcription factors to the Robo4 promoter. In elecrophoretic mobility shift assay, DNA methylation had no effect on GABP binding to the −119 ETS or SP1 binding to the −153 SP1 site. In contrast, DNA methylation inhibited binding of SP1 to the −42 SP1 site. Because −42 SP1, but not to the −153 SP1, site contains an internal CpG site, methylationdependent inhibition of transcription factor binding seems to be more effective when the SP1 and CpG sites overlap. In any event, our data suggest that DNA methylation at the −42 SP1 site plays a role in repressing Robo4 expression in non-ECs.
We next investigated whether DNA methylation of the promoter induces chromatin condensation, which is associated with inhibition of transcription factor binding to the promoter. Our DNase hypersensitivity assays indicated that chromatin is strongly condensed at −2.5 kb, where highly methylated CpG sites were observed in both ECs and non-ECs. In contrast, chromatin condensation of the proximal promoter region, while low in ECs, was variable in non-ECs. Thus, chromatin condensation is not a universal requirement for Robo4 gene suppression in non-ECs.
We have shown that the proximal promoter of Robo4 is demethylated during ES cell differentiation into Flk-1 + cells. We repeated these assays using ES cells targeted with a Robo4 promoter containing mutated GABP-or SP1-binding sites. The WT and mutant promoters demonstrated comparable differentiation-dependent demethylation. Thus, binding of GABP and SP1 to the proximal promoter does not seem to mediate demethylation in differentiating ECs. Additional studies are required to determine the underlying mechanism.
It is interesting to speculate that DNA methylation is dynamically regulated in ECs and contributes to physiological modulation of Robo4 expression. A previous study demonstrated that Robo4 expression is inhibited by shear stress. We confirmed these findings but were unable to demonstrate flow-mediated changes in Robo4 promoter methylation. Thus, other mechanisms are likely to be responsible for Robo4 gene repression under shear stress conditions. Perhaps this is not surprising because the methylation status of DNA is a relatively stable mark and may change over longer time scales than those used in the present experiments.
A comparison of LacZ expression in Hprt-targeted mice carrying the 3-kb and 0.3-kb upstream promoter regions of Robo4 indicates that although the shorter DNA fragment is sufficient for EC-specific expression, DNA sequences between 0.3 and 3 kb are necessary for full activity in the microvasculature. We identified enhancer elements at −2.5 kb (REn1 [Robo4 enhancer element]) and −2.9 kb (REn2) that are essential for maximal promoter activation. 10 Because REn1 is located in the region where DNA methylation and chromatin condensation are observed, REn1 may contribute to activation of the Robo4 promoter through epigenetic control.
In summary, our study supports a model in which EC-specific expression of Robo4 is mediated, at least in part, by DNA methylation-dependent inhibition of SP1 binding to −42 SP1 in non-ECs. Furthermore, the data suggest the existence of an EC-specific regulator that induces demethylation of Robo4 (and perhaps, by extension, other EC-specific genes) during cell differentiation.
